Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

Similar articles for PubMed (Select 22864375)

1.

Comparison of two different iron oxide-based contrast agents for discrimination of benign and malignant lymph nodes.

Kinner S, Maderwald S, Albert J, Parohl N, Corot C, Robert P, Baba HA, Barkhausen J.

Invest Radiol. 2012 Sep;47(9):511-5. doi: 10.1097/RLI.0b013e3182587744.

PMID:
22864375
2.

Discrimination of benign and malignant lymph nodes at 7.0T compared to 1.5T magnetic resonance imaging using ultrasmall particles of iron oxide: a feasibility preclinical study.

Kinner S, Maderwald S, Albert J, Parohl N, Corot C, Robert P, Baba HA, Barkhausen J.

Acad Radiol. 2013 Dec;20(12):1604-9. doi: 10.1016/j.acra.2013.09.004.

PMID:
24200489
3.

Assessment of normal, inflammatory, and tumor-bearing lymph nodes with contrast-enhanced interstitial magnetic resonance lymphography: preliminary results in rabbits.

Herborn CU, Vogt FM, Lauenstein TC, Goyen M, Dirsch O, Corot C, Debatin JF, Ruehm SG.

J Magn Reson Imaging. 2003 Sep;18(3):328-35.

PMID:
12938128
4.
5.

Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR) -- results of a phase-III multicenter clinical trial.

Sigal R, Vogl T, Casselman J, Moulin G, Veillon F, Hermans R, Dubrulle F, Viala J, Bosq J, Mack M, Depondt M, Mattelaer C, Petit P, Champsaur P, Riehm S, Dadashitazehozi Y, de Jaegere T, Marchal G, Chevalier D, Lemaitre L, Kubiak C, Helmberger R, Halimi P.

Eur Radiol. 2002 May;12(5):1104-13. Epub 2001 Oct 18.

PMID:
11976854
6.

Does quantification of USPIO uptake-related signal loss allow differentiation of benign and malignant normal-sized pelvic lymph nodes?

Froehlich JM, Triantafyllou M, Fleischmann A, Vermathen P, Thalmann GN, Thoeny HC.

Contrast Media Mol Imaging. 2012 May-Jun;7(3):346-55. doi: 10.1002/cmmi.503.

PMID:
22539405
7.

[Lymph node image with ultrasmall superparamagnetic iron oxide and comparison with pathological result].

Xue HD, Lei J, Li Z, Wang DT, Zhou WX, Dai W, Jin ZY.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2009 Apr;31(2):139-45. Chinese.

8.

MR contrast agents in lymph node imaging.

Misselwitz B.

Eur J Radiol. 2006 Jun;58(3):375-82. Epub 2006 Feb 7. Review.

PMID:
16464554
9.

Anti-inflammatory drug evaluation in ApoE-/- mice by ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.

Sigovan M, Kaye E, Lancelot E, Corot C, Provost N, Majd Z, Breisse M, Canet-Soulas E.

Invest Radiol. 2012 Sep;47(9):546-52. doi: 10.1097/RLI.0b013e3182631e68.

PMID:
22864378
10.

Interstitial MR lymphography with iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits.

Taupitz M, Wagner S, Hamm B, Binder A, Pfefferer D.

AJR Am J Roentgenol. 1993 Jul;161(1):193-200.

PMID:
8517301
11.

Characterization of reactive versus tumor-bearing lymph nodes with interstitial magnetic resonance lymphography in an animal model.

Vassallo P, Matei C, Heston WD, McLachlan SJ, Koutcher JA, Castellino RA.

Invest Radiol. 1995 Dec;30(12):706-11.

PMID:
8748183
12.

Contrast-enhanced magnetic resonance angiography in rabbits: evaluation of the gadolinium-based agent p846 and the iron-based blood pool agent p904 in comparison with gadoterate meglumine.

Kinner S, Maderwald S, Parohl N, Albert J, Corot C, Robert P, Barkhausen J, Vogt FM.

Invest Radiol. 2011 Aug;46(8):524-9. doi: 10.1097/RLI.0b013e31821ae21f.

PMID:
21577130
13.

Iron oxide particle-enhanced magnetic resonance imaging for detection of benign lymph nodes in the head and neck: how reliable are the results?

Baghi M, Mack MG, Wagenblast J, Hambek M, Rieger J, Bisdas S, Gstoettner W, Engels K, Vogl T, Knecht R.

Anticancer Res. 2007 Sep-Oct;27(5B):3571-5.

14.

[Comparison between Gd-DTPA-enhanced MRI and USPIO-enhanced MRI in diagnosing benign and metastatic cervical lymph nodes in rabbit models].

Feng Y, Zhang GX, Wang H, Hu YS, Wang XF, Zheng LF.

Zhonghua Zhong Liu Za Zhi. 2010 Nov;32(11):813-8. Chinese.

PMID:
21223685
15.

Possible pathological basis for false diagnoses of lymph nodes by USPIO-enhanced MRI in rabbits.

Lei J, Xue HD, Li Z, Li S, Jin ZY.

J Magn Reson Imaging. 2010 Jun;31(6):1428-34. doi: 10.1002/jmri.22190.

PMID:
20512896
16.
17.

MR imaging of pelvic lymph nodes in primary pelvic carcinoma with ultrasmall superparamagnetic iron oxide (Combidex): preliminary observations.

Harisinghani MG, Saini S, Slater GJ, Schnall MD, Rifkin MD.

J Magn Reson Imaging. 1997 Jan-Feb;7(1):161-3.

PMID:
9039609
18.

[Contrast media for magnetic resonance tomographic lymph node diagnosis (MR lymphography)].

Taupitz M, Wagner S, Hamm B.

Radiologe. 1996 Feb;36(2):134-40. Review. German.

PMID:
8867430
19.

Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancer.

Triantafyllou M, Studer UE, Birkhäuser FD, Fleischmann A, Bains LJ, Petralia G, Christe A, Froehlich JM, Thoeny HC.

Eur J Cancer. 2013 Feb;49(3):616-24. doi: 10.1016/j.ejca.2012.09.034. Epub 2012 Oct 18.

20.

Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer.

Rockall AG, Sohaib SA, Harisinghani MG, Babar SA, Singh N, Jeyarajah AR, Oram DH, Jacobs IJ, Shepherd JH, Reznek RH.

J Clin Oncol. 2005 Apr 20;23(12):2813-21. Erratum in: J Clin Oncol. 2005 Jul 20;23(21):4808.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk